Amygdala Neurosciences Announces FDA Clearance of Investigational New Drug (IND) Application for ANS-858
Latest PR Newswire FDA coverage of Amygdala Neurosciences Announces FDA Clearance of Investigational New Drug (IND)
Amygdala Neurosciences
Private
Clinical-stage neuroscience company developing treatments for substance use disorders and neurological conditions.
Company Info
Sector:Neuroscience / Small Molecule Pharma
Headquarters:United States
Founded:2015
Website:amygns.com/